HIV-1 Nef AND HOST CELL PROTEIN KINASES

Kalle Saksela

Institute of Medical Technology, University of Tampere, P.O. Box 607, FIN-33101, Tampere, Finland

Received 11/10/97 Accepted 11/17/97

5. REFERENCES

1. H. Kestler, D. J., Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel & R. C. Desrosiers: Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662 (1991).

2. M. D. Daniel, F. Kirchhoff, S. C. Czajak, P. K. Sehgal & R. C. Desrosiers: Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941 (1992).

3. N. J. Deacon, A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton & J. Mills: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270, 988-991 (1995).

4. F. Kirchhoff, T. C. Greenough, D. B. Brettler, J. L. Sullivan & R. C. Desrosiers: Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332, 228-232 (1995).

5. M. D. Miller, M. T. Warmerdam, I. Gaston, W. C. Greene & M. B. Feinberg: The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179, 101-113 (1994).

6. C. A. Spina, T. J. Kwoh, M. Y. Chowers, J. C. Guatelli & D. D. Richman: The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179, 115-23 (1994).

7. C. Aiken & D. Trono: Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69, 5048-5056 (1995).

8. M. Y. Chowers, C. A. Spina, T. J. Kwoh, N. J. Fitch, D. D. Richman & J. C. Guatelli: Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68, 2906-2914 (1994).

9. M. Y. Chowers, M. W. Pandori, C. A. Spina, D. D. Richman & J. C. Guatelli: The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212, 451-457 (1995).

10. M. D. Miller, M. T. Warmerdam, K. A. Page, M. B. Feinberg & W. C. Greene: Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69, 579-584 (1995).

11. O. Schwartz, V. Marechal, O. Danos & J. M. Heard: Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69, 4053-4059 (1995).

12. M. W. Pandori, N. J. Fitch, H. M. Craig, D. D. Richman, C. A. Spina & J. C. Guatelli: Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70, 4283-4290 (1996).

13. R. Welker, H. Kottler, H. R. Kalbitzer & H. G. Krausslich: Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219, 228-236 (1996).

14. M. D. Miller, M. T. Warmerdam, S. S. Ferrell, R. Benitez & W. C. Greene: Intravirion generation of the C-terminal core domain of HIV-1 Nef by the HIV-1 protease is insufficient to enhance viral infectivity. Virology 234, 215-225 (1997).

15. S. Swingler, P. Gallay, D. Camaur, J. Song, A. Abo & D. Trono: The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71, 4372-4377 (1997).

16. S. Anderson, D. C. Shugars, R. Swanstrom & J. V. Garcia: Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J. Virol. 67, 4923-4931 (1993).

17. J. V. Garcia & A. D. Miller: Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350, 508-511 (1991).

18. B. Guy, M. Paule Kieny, Y. Riviere, C. Le Peuch, K. Dott, M. Girard, L. Montagnier & J.-P. Lecocq: HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 30, 266-269 (1987).

19. R. Mariani & J. Skowronski: CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc. Natl. Acad. Sci. USA 90, 5549-5553 (1993).

20. S. LeGall, M. C. Prevost, J. M. Heard & O. Schwartz: Human immunodeficiency virus type 1 Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virion infectivity. Virology 229, 295-301 (1997).

21. O. Schwartz, V. Marechal, G. S. Le, F. Lemonnier & J. M. Heard: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med. 2, 338-342 (1996).

22. C. Aiken, J. Konner, N. R. Landau, M. E. Lenburg & D. Trono: Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76, 853-864 (1994).

23. M. A. Pelchen, I. J. Parsons & M. Marsh: Phorbol ester-induced downregulation of CD4 is a multistep process involving dissociation from p56lck, increased association with clathrin-coated pits, and altered endosomal sorting. J. Exp. Med. 178, 1209-1222 (1993).

24. S. Salghetti, R. Mariani & J. Skowronski: Human immunodeficiency virus type 1 Nef and p56lck protein-tyrosine kinase interact with a common element in CD4 cytoplasmic tail. Proc. Nat. Acad. Sci. USA 92, 349-353 (1995).

25. K. Saksela, G. Cheng & D. Baltimore: Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14, 484-491 (1995).

26. M. A. Goldsmith, M. T. Warmerdam, R. E. Atchison, M. D. Miller & W. C. Greene: Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69, 4112-4121 (1995).

27. J. Hua, W. Blair, R. Truant & B. R. Cullen: Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology 231, 231-238 (1997).

28. A. J. Iafrate, S. Bronson & J. Skowronski: Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16, 673-684 (1997).

29. M. Wiskerchen & C. Cheng-Mayer: HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 224, 292-301 (1996).

30. G. N. Pavlakis, S. Schwartz, D. M. D'Agostino & B. K. Felber: Structure, splicing, and regulation of expression of HIV-1: A model for the general organization of lentiviruses and other complex retroviruses. In: Annual Review of AIDS Research, Eds: R. Kennedy, F. Wong-Staal, and W.C. Koff , Marcel Dekker, New York. 41-63 (1991)

31. L. Alexander, Z. Du, M. Rosenzweig, J. U. Jung & R. C. Desrosiers: A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J. Virol. 71, 6094-6099 (1997).

32. Z. Du, S. M. Lang, V. G. Sasseville, A. A. Lackner, P. O. Ilyinskii, M. D. Daniel, J. U. Jung & R. C. Desrosiers: Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82, 665-674 (1995).

33. S. D. Briggs, M. Sharkey, M. Stevenson & T. E. Smithgall: SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272, 17899-17902 (1997).

34. N. Ahmad & S. Venkatesan: Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR. Science 241, 1481-1485 (1988).

35. J. C. Bandres & L. Ratner: Human immunodeficiency virus type 1 Nef-protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J. Virol. 68, 3243-3249 (1994).

36. A. S. Baur, E. T. Sawai, P. Dazin, W. J. Fantl, C. Cheng-Mayer & B. M. Peterlin: HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384 (1994).

37. R. Carreer, H. Groux, J. C. Ameisen & A. Capron: Role of HIV-1 Nef expression in activation pathways in CD4+ T cells. Aids Res. Hum. Retroviruses 10, 523-527 (1994).

38. S. K. De & J. W. Marsh: HIV-1 Nef inhibits a common activation pathway in NIH-3T3 cells. J. Biol. Chem. 269, 6656-6660 (1994).

39. Y. Collette, C. Mawas & D. Olive: Evidence for intact CD28 signaling in T cell hyporesponsiveness induced by the HIV-1 nef gene. Eur. J. Immunol. 26, 1788-1793 (1996).

40. Y. Collette, H. L. Chang, C. Cerdan, H. Chambost, M. Algarte, C. Mawas, J. Imbert, A. Burny & D. Olive: Specific Th1 cytokine down-regulation associated with primary clinically derived human immunodeficiency virus type 1 Nef gene-induced expression. J. Immunol. 156, 360-370 (1996).

41. A. Graziani, F. Galimi, E. Medico, E. Cottone, D. Gramaglia, C. Boccaccio & P. Comoglio: The HIV-1 Nef protein interferes with phosphatidylinositol 3-kinase activation. J. Biol. Chem. 271, 6590-6593 (1996).

42. A. Greenway, A. Azad & D. McPhee: Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69, 1842-1850 (1995).

43. X. Lu, X. Wu, A. Plemenitas, H. Yu, E. T. Sawai, A. Abo & B. M. Peterlin: CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6, 1677-1684 (1996).

44. T. M. Niederman, W. R. Hastings, S. Luria, J. C. Bandres & L. Ratner: HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology 194, 338-344 (1993).

45. K. A. Page, S. W. van & M. B. Feinberg: Human immunodeficiency virus type 1 Nef does not alter T-cell sensitivity to antigen-specific stimulation. J. Virol. 71, 3776-3787 (1997).

46. O. Schwartz, S. F. Arenzana, J. M. Heard & O. Danos: Activation pathways and human immunodeficiency virus type 1 replication are not altered in CD4+ T cells expressing the nef protein. AIDS Res. Hum. Retroviruses 8, 545-551 (1992).

47. J. Skowronski, D. Parks & R. Mariani: Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12, 703-713 (1993).

48. C. H. Lee, B. Leung, M. A. Lemmon, J. Zheng, D. Cowburn, J. Kuriyan & K. Saksela: A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein. EMBO J. 14, 5006-5015 (1995).

49. C. H. Lee, K. Saksela, U. A. Mirza, B. T. Chait & J. Kuriyan: Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85, 931-942 (1996).

50. I. Moarefi, B. M. LaFevre, F. Sicheri, M. Huse, C. H. Lee, J. Kuriyan & W. T. Miller: Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385, 650-653 (1997).

51. A. Greenway, A. Azad, J. Mills & D. McPhee: Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70, 6701-6708 (1996).

52. Y. Collette, H. Dutartre, A. Benziane, M. Romas, R. Benarous, M. Harris & D. Olive: Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J. Biol. Chem. 271, 6333-6341 (1996).

53. A. S. Baur, G. Sass, B. Laffert, D. Willbold, C. Cheng-Mayer & B. M. Peterlin: The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6, 283-291 (1997).

54. E. T. Sawai, A. Baur, H. Struble, B. M. Peterlin, J. A. Levy & C. Cheng-Mayer: Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Nat. Acad. Sci. USA 91, 1539-1543 (1994).

55. E. T. Sawai, A. S. Baur, B. M. Peterlin, J. A. Levy & C. Cheng-Mayer: A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270, 15307-15314 (1995).

56. E. T. Sawai, I. H. Khan, P. M. Montbriand, B. M. Peterlin, C. Cheng-Mayer & P. A. Luciw: Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr. Biol. 6, 1519-1527 (1996).

57. M. F. Nunn & J. W. Marsh: Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70, 6157-6161 (1996).

58. B. L. Smith, B. W. Krushelnycky, R. D. Mochly & P. Berg: The HIV nef protein associates with protein kinase C theta. J. Biol. Chem. 271, 16753-16757 (1996).

59. M. Bodeus, C. A. Marie, C. Bougeret, M. F. Ramos & R. Benarous: In vitro binding and phosphorylation of human immunodeficiency virus type 1 Nef protein by serine/threonine protein kinase. J. Gen. Virol. 76, 1337-1344 (1995).

60. S. Grzesiek, A. Bax, G. M. Clore, A. M. Gronenborn, J. S. Hu, J. Kaufman, I. Palmer, S. J. Stahl & P. T. Wingfield: The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Struct. Biol. 3, 340-345 (1996).

61. M. P. Harris & J. C. Neil: Myristoylation-dependent binding of HIV-1 Nef to CD4. J. Mol. Biol. 241, 136-142 (1994).

62. F. Rossi, A. Gallina & G. Milanesi: Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology 217, 397-403 (1996).

63. L. X. Liu, F. Margottin, S. Legall, O. Schwartz, L. Selig, R. Benarous & S. Benichou: Binding of HIV-1 Nef to a novel thioesterase enzyme correlates with Nef-mediated CD4 down-regulation. J. Biol. Chem. 272, 13779-13785 (1997).

64. S. Benichou, M. Bomsel, M. Bodeus, H. Durand, M. Doute, F. Letourneur, J. Camonis & R. Benarous: Physical interaction of the HIV-1 Nef protein with beta-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269, 30073-30076 (1994).

65. O. T. Fackler, N. Kienzle, E. Kremmer, A. Boese, B. Schramm, T. Klimkait, C. Kucherer & N. Muellerlantzsch: Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247, 843-851 (1997).

66. M. Greenberg, S. Bronson, M. Lock, M. Neumann, G. N. Pavlakis & J. Skowronski: Colocalization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 downregulation. EMBO J. In press. (1997).

67. P. Cicchetti, B. J. Mayer, G. Thiel & D. Baltimore: Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257, 803-806 (1992).

68. R. Ren, B. J. Mayer, P. Cicchetti & D. Baltimore: Identification of a ten-amino acid proline-rich SH3 binding site. Science 259, 1157-1161 (1993).

69. G. B. Cohen, R. Ren & D. Baltimore: Modular binding domains in signal transduction proteins. Cell 80, 237-248 (1995).

70. M. Sudol: Nonreceptor protein tyrosine kinases. In: The Molecular Basis of Human Cancer, Eds: B. Neel and R. Kumar. Futura Publishing Co, Inc., Mount Kisco, NY. 203-224. (1993).

71. P. M. Brickell: The p60c-src family of protein-tyrosine kinases: structure, regulation, and function. Crit. Rev. Oncogen. 3, 401-446 (1992).

72. F. Sicheri, I. Moarefi & J. Kuriyan: Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609 (1997).

73. W. Xu, S. C. Harrison & M. J. Eck: Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602 (1997).

74. W. A. Lim, F. M. Richards & R. O. Fox: Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains. Nature 372, 375-379 (1994).

75. S. Feng, J. K. Chen, H. Yu, J. A. Simon & S. L. Schreiber: Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science 266, 1241-1247 (1994).

76. S. M. Lang, A. J. Iafrate, C. Stahl-Hennig, E. M. Kuhn, T. Nisslein, F.-J. Kaup, M. Haupt, G. Hunsmann, J. Skowronski & F. Kirchhoff: Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nature Med. 3, 860-865 (1997).

77. T. W. Baba, Y. S. Jeong, D. Pennick, R. Bronson, M. F. Greene & R. M. Ruprecht: Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825 (1995).

78. J. Cohen: Weakened SIV vaccine still kills. Science 278, 24-25 (1997).

79. J. Y. Kato, T. Takeya, C. Grandori, H. Iba, J. B. Levy & H. Hanafusa: Amino acid substitutions sufficient to convert the nontransforming p60c-src protein to a transforming protein. Mol. Cell. Biol. 6, 4155-4160 (1986).

80. S. M. Murphy, M. Bergman & D. O. Morgan: Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae. Mol. Cell. Biol. 13, 5290-5300 (1993).

81. H. Yamaguchi & W. A. Hendrickson: Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384, 484-489 (1996).

82. S. S. Frankel, B. M. Wenig, A. P. Burke, P. Mannan, L. D. Thompson, S. L. Abbondanzo, A. M. Nelson, M. Pope & R. M. Steinman: Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science 272, 115-117 (1996).

83. M. Pope, M. G. Betjes, N. Romani, H. Hirmand, P. U. Cameron, L. Hoffman, S. Gezelter, G. Schuler & R. M. Steinman: Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78, 389-398 (1994).

84. J. M. Orenstein, C. Fox & S. M. Wahl: Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861 (1997).

85. M. Harris & K. Coates: Identification of cellular proteins that bind to the human immunodeficiency virus type 1 nef gene product in vitro: a role for myristylation. J. Gen. Virol.. 74, 1581-1589 (1993).

86. L. Poulin & J. A. Levy: The HIV-1 nef gene product is associated with phosphorylation of a 46 kD cellular protein. AIDS 6, 787-791 (1992).

87. K. Coates & M. Harris: The human immunodeficiency virus type 1 Nef protein functions as a protein kinase C substrate in vivo. J. Gen. Virol. 76, 837-844 (1995).

87. K. Coates, S. Cooke, D. Mann & M. Harris: Protein kinase C mediated phosphorylation of HIV-1 Nef in human cell lines. J. Biol. Chem. 272, 12289-12294 (1997).

89. J. C. Bandres, S. Luria & L. Ratner: Regulation of human immunodeficiency virus Nef protein by phosphorylation. Virology 201, 157-161 (1994).

90. T. Luo, J. R. Downing & J. V. Garcia: Induction of phosphorylation of human immunodeficiency virus type 1 Nef and enhancement of CD4 downregulation by phorbol myristate acetate. J. Virol. 71, 2535-2539 (1997).

91. L. Lim, E. Manser, T. Leung & C. Hall: Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. Eur. J. Biochem. 242, 171-185 (1996).

92. T. Luo & J. V. Garcia: The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70, 6493-6496 (1996).

93. D. C. Shugars, M. S. Smith, D. H. Glueck, P. V. Nantermet, F. Seillier-Moiseiwitsch & R. Swanstrom: Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 67, 4639-4650 (1993).

94. J. Hua & B. R. Cullen: Human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus use distinct but overlapping sites for downregulation of cell surface CD4. J. Virol. 71, 6742-6748 (1997).

95. N. Isakov: Immunoreceptor tyrosine-based activation motif (ITAM), a unique module linking antigen and Fc receptors to their signaling cascades. J. Leukoc. Biol. 61, 6-16 (1997).